UBS Group’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,920
Closed -$15.8K 9462
2024
Q4
$15.8K Buy
7,920
+1,777
+29% +$3.55K ﹤0.01% 6793
2024
Q3
$15.3K Buy
6,143
+5,470
+813% +$13.6K ﹤0.01% 6308
2024
Q2
$2.36K Buy
+673
New +$2.36K ﹤0.01% 7210
2024
Q1
Sell
-14
Closed -$174 8751
2023
Q4
$174 Buy
+14
New +$174 ﹤0.01% 7629
2023
Q1
Sell
-17
Closed -$1.45K 9199
2022
Q4
$1.45K Buy
17
+2
+13% +$170 ﹤0.01% 8664
2022
Q3
$11K Sell
15
-13
-46% -$9.53K ﹤0.01% 7241
2022
Q2
$9K Hold
28
﹤0.01% 7150
2022
Q1
$15K Buy
28
+4
+17% +$2.14K ﹤0.01% 6816
2021
Q4
$25K Buy
24
+18
+300% +$18.8K ﹤0.01% 6483
2021
Q3
$10K Buy
6
+5
+500% +$8.33K ﹤0.01% 6882
2021
Q2
$3K Sell
1
-4
-80% -$12K ﹤0.01% 7739
2021
Q1
$34K Buy
5
+2
+67% +$13.6K ﹤0.01% 5895
2020
Q4
$23K Hold
3
﹤0.01% 5838
2020
Q3
$32K Sell
3
-3
-50% -$32K ﹤0.01% 5100
2020
Q2
$68K Buy
6
+4
+200% +$45.3K ﹤0.01% 4791
2020
Q1
$18K Hold
2
﹤0.01% 5655
2019
Q4
$19K Sell
2
-2
-50% -$19K ﹤0.01% 5842
2019
Q3
$28K Sell
4
-1
-20% -$7K ﹤0.01% 5574
2019
Q2
$36K Buy
5
+1
+25% +$7.2K ﹤0.01% 5331
2019
Q1
$23K Buy
4
+1
+33% +$5.75K ﹤0.01% 5368
2018
Q4
$17K Buy
3
+1
+50% +$5.67K ﹤0.01% 5995
2018
Q3
$7K Sell
2
-2
-50% -$7K ﹤0.01% 6426
2018
Q2
$18K Buy
4
+1
+33% +$4.5K ﹤0.01% 5862
2018
Q1
$17K Sell
3
-6
-67% -$34K ﹤0.01% 5645
2017
Q4
$35K Buy
+9
New +$35K ﹤0.01% 5170
2017
Q3
Sell
-1
Closed -$9K 6933
2017
Q2
$9K Buy
+1
New +$9K ﹤0.01% 5907